二甲雙胍對糖尿病大鼠血清CTRP9水平的影響及其治療效應(yīng)的評估
[Abstract]:Background Diabetes mellitus, a common chronic disease, has increased year by year. Up to now, about 250 million people worldwide have suffered from the disease. By 2025, this number may reach about 400 million. The World Health Organization (WHO) predicts that compared with developed countries, developing countries have suffered from the disease. The number of people with diabetes will rise more quickly, due to unhealthy diet, aging, obesity and many other factors. According to the World Health Organization, the majority of people with diabetes in developing countries will be around 35-65 years old in 2015, which is the golden time for one person to work and produce diabetes in developed countries. In 2016, the theme of World Health Day is "We need more action to deal with diabetes." From the above data, we can see that the whole human race must begin to pay more attention to diabetes. On the one hand, we need to pay attention to the damage caused by diabetes, such as the occurrence of complications, such as week. Peripheral neuropathy, autonomic neuropathy, retinopathy, cardiovascular hazards, and so on. On the other hand, we should strengthen the health education of diabetic patients, promote the knowledge of diabetes, in-depth interpretation of the relevant knowledge in high-risk groups of diabetes. In short, the prevention and treatment of diabetes is urgent. There are many factors of diabetes, can be left behind. Transmission, immunity, microorganisms and their toxins, free radicals, mental factors and so on all kinds of reasons affect the body, and then lead to islet dysfunction, insulin resistance, due to the relative or absolute insufficiency of insulin secretion, or insulin deficiency, resulting in the body sugar, fat and electrolyte and a series of metabolic disorders syndrome, clinical hyperglycemia as The main characteristics, and persistently elevated blood glucose, lipids on the one hand will cause damage to the body, but also induce beta cell dysfunction and insulin resistance, which are closely related to oxidative stress and chronic inflammation, it can be said that oxidative stress throughout the occurrence and development of diabetes mellitus. There are fifteen members in the CTRPs family with similar structure and positive effect. It plays an important role in the prevention of oxidative stress, insulin resistance and cardiovascular disease. Some scholars have found that there is no metabolic disorder in mice after APN gene deletion, which indicates that there may be other factors or mechanisms in the body to compensate for the lack of APN. This effect may be compensated by CTRPs. Because of the similarity of the CTRPs family and APN structure and biological characteristics, it is learned. It is speculated that CTRP9 is involved in the above mechanisms. Further clarification of the physiological effects of CTRP9 and its association with cardiovascular diseases, obesity and diabetes mellitus may provide new ideas and methods for the treatment of chronic metabolic diseases. In recent years, some other effects of metformin have been known by more and more people, such as anti-inflammatory, anti-tumor, anti-oxidative stress and so on, but for its antioxidant effect The mechanism of chemical stress is still lack of clinical and basic experimental support. 2 Materials and Methods 2.1 Grouping and feeding SPF SD male rats with a body weight of 89.62+7.42 g were randomly divided into two groups after 7 days of adaptive feeding. One group of 10 rats and the other 30 rats were fed with normal diet, high fat and high sugar diet respectively, and STZ was injected intraperitoneally at the 8th week. The model was established by STZ+high-fat and high-glucose combined with intraperitoneal injection of 30mg/kg. The fasting blood glucose was measured 3 days later. The fasting blood glucose was more than 15mmol/L. The model group was randomly divided into three groups, 10 rats in each group. One group was fed with high-fat and high-sugar (M+MET), the other with high-fat and high-glucose + insulin (M+I). Normal diet group was fed with normal feeding (group C, 10 rats). MET was given 200 mg/kg by gastric lavage, rats without MET were given normal saline by gastric lavage. Blood samples were fed for 12 weeks. 2.2 observation indexes (1) Blood glucose concentration (glucose oxidase method) and insulin content (radioimmunoassay) were used to calculate insulin resistance index (2) ELISA method to detect blood glucose concentration (glucose oxidase method). The expression levels of CTRP9, TNF-alpha in serum (3) Western blot were used to detect the expression levels of IKK-beta and ser181 protein (4) RT-PCR was used to detect the expression levels of CTRP9, TNF-alpha and IL-6 gene. Results 3.1 The difference of HOMA-IR levels in serum of rats in each HOMA-IR group was statistically significant (F=169.923, P=0.0000.05). The HOMA-IR levels in M group, M+Ins group and M+Met group were all significantly different. Compared with the control group, the difference was statistically significant (P 0.05). The HOMA-IR of M+Ins group and M+Met group was lower than that of M group, and the difference was statistically significant (P 0.05). See Table 3.1, 3.2.3.2, the expression of CTRP9 in serum of rats skeletal muscle tissue in each group was statistically significant (F = 98.773, P = 0.0000.05). The levels of CTRP9 in group E were higher than those in group M (P 0.05). The levels of CTRP9 in group M + Ins and group M + M ET were lower than those in group C (P 0.05). The expression levels of CTRP9, TNF-a and IL-6 in skeletal muscle tissue of rats in each group were significantly lower than those in group C (P 0.05), and the expression levels of CTRP9 mRNA in adipocytes of rats in group M were significantly higher than those in group M + Ins and group M + Met (P 0.05). Compared with group M, the expression level of TNF-alpha mRNA in skeletal muscle of rats in group M was significantly decreased (P 0.05); compared with group M, the expression level of TNF-alpha mRNA in group M + Ins and group M + Met was significantly increased (P 0.05). Compared with group C, the expression level of IL-6 mRNA in skeletal muscle of rats in group M was significantly decreased (P 0.05). The expression of IL-6 mRNA in M+Met group was significantly higher than that in M+Met group. 3.5 The expression of IKK-beta and ser181 protein in skeletal muscle tissue of rats in each group was statistically significant. Conclusion (1) The expression of CTRP9 in serum of type 2 diabetic rats was decreased. (2) Insulin resistance in type 2 diabetic rats was negatively correlated with the expression of CTRP9. (3) Metformin decreased the expression of CTRP9 in skeletal muscle tissue of diabetic rats The expression of ser181 protein had little effect on IKK-beta. (4) Metformin may inhibit the phosphorylation of IKK-beta.
【學(xué)位授予單位】:鄭州大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2017
【分類號】:R587.2
【參考文獻】
相關(guān)期刊論文 前10條
1 高曉琳;萬朝敏;;兒童肥胖癥與腸道菌群相關(guān)性的研究進展[J];中國當(dāng)代兒科雜志;2017年03期
2 朱洪竹;阮曉娟;朱梅菊;曾志剛;肖國強;;運動訓(xùn)練對2型糖尿病大鼠腎臟NF-κB-p65和相關(guān)蛋白表達(dá)的影響及機制研究[J];體育科學(xué);2016年08期
3 樊春荔;吳嘉;汪俊軍;;心血管疾病氧化應(yīng)激反應(yīng)相關(guān)microRNAs的研究進展[J];臨床檢驗雜志;2015年10期
4 Francesco Paneni;Sarah Costantino;Francesco Cosentino;;Role of oxidative stress in endothelial insulin resistance[J];World Journal of Diabetes;2015年02期
5 萬基偉;樊小農(nóng);王舒;劉健;;氧化應(yīng)激與高血壓發(fā)病機制研究[J];中醫(yī)學(xué)報;2015年01期
6 劉頤軒;宋桉;王蕓;段力園;宋光耀;;氧化應(yīng)激在肥胖及胰島素抵抗中的作用研究進展[J];解放軍醫(yī)藥雜志;2014年01期
7 陳燕;黃蘇萍;;ROS、SOD、GSH在糖尿病血管病變中的研究近況[J];江西中醫(yī)學(xué)院學(xué)報;2013年03期
8 葛蓓蕾;田陸云;王紅;;華法林個體化用藥的研究進展[J];中國老年學(xué)雜志;2012年10期
9 陳霽暉;楊寶學(xué);周虹;;心血管疾病中氧化應(yīng)激與一氧化氮合酶脫耦聯(lián)[J];中國心血管雜志;2012年02期
10 施麗麗;任明山;吳元潔;;糖尿病周圍神經(jīng)病變與氧化應(yīng)激研究現(xiàn)狀[J];安徽醫(yī)科大學(xué)學(xué)報;2012年01期
相關(guān)博士學(xué)位論文 前2條
1 季光;ERK通路在氧化應(yīng)激中對GRASP65及高爾基體形態(tài)的影響[D];中南大學(xué);2013年
2 劉師偉;脂肪細(xì)胞因子與胰島素抵抗和2型糖尿病患者代謝綜合征臨床表型的關(guān)系及機制的研究[D];山西醫(yī)科大學(xué);2009年
相關(guān)碩士學(xué)位論文 前1條
1 李佳;2型糖尿病脂代謝紊亂臨床證候分布及Quassia amara干預(yù)作用機制研究[D];北京中醫(yī)藥大學(xué);2014年
,本文編號:2219134
本文鏈接:http://sikaile.net/yixuelunwen/nfm/2219134.html